• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡介苗复种在结核病发病率低的情况下存在疑问。

Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence.

作者信息

Tala-Heikkilä M M, Tuominen J E, Tala E O

机构信息

Department of Paediatrics, Turku University Central Hospital, University of Turku, Finland.

出版信息

Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1324-7. doi: 10.1164/ajrccm.157.4.9706037.

DOI:10.1164/ajrccm.157.4.9706037
PMID:9563757
Abstract

Bacillus Calmette-Guerin (BCG) revaccination was discontinued in Finland in 1990. The objective of this study was to assess the impact of BCG revaccination of tuberculin-negative school-children in prevention of tuberculosis. The tuberculosis cases in 1990-1995 were calculated among age cohorts born 1979-1984 and no longer covered by the BCG revaccination program. Corresponding data were collected for comparison from the period of revaccination in 1980-1985 among age cohorts born in 1969-1974. The National Tuberculosis Register was reviewed in order to observe the tuberculosis trend since 1980 in the age groups of 10-14 and 15-19 yr. Three cases of tuberculosis have been registered among non-BCG-revaccinated children during 6 yr after discontinuation of the program, i.e., 2.23 cases (95% CI 0.72 to 6.90) per million person yr. The control group revealed five cases, 3.78 (95% CI 1.57 to 9.07) per million person yr. The relative risk of tuberculosis in non-BCG-revaccinated children is 0.59 (95% CI 0.14 to 2.47) compared with the control group. The incidence of tuberculosis has continued to decline among adolescents since 1980. The follow-up data confirm that the cessation of BCG revaccination program had no effect on the continuing overall decline of tuberculosis in Finland. The efficacy of BCG revaccination seems to be low or nonexistent in countries with low tuberculosis incidence.

摘要

1990年芬兰停止了卡介苗(BCG)复种。本研究的目的是评估对结核菌素阴性的学童进行卡介苗复种在预防结核病方面的影响。计算了1979 - 1984年出生、不再纳入卡介苗复种计划的年龄队列在1990 - 1995年期间的结核病病例数。从1980 - 1985年复种期间1969 - 1974年出生的年龄队列收集了相应数据进行比较。查阅了国家结核病登记册,以观察1980年以来10 - 14岁和15 - 19岁年龄组的结核病趋势。在该计划停止后的6年里,未接种卡介苗复种的儿童中登记了3例结核病,即每百万人年2.23例(95%可信区间0.72至6.90)。对照组有5例,每百万人年3.78例(95%可信区间1.57至9.07)。与对照组相比,未接种卡介苗复种儿童患结核病的相对风险为0.59(95%可信区间0.14至2.47)。自198起,青少年结核病发病率持续下降。随访数据证实,芬兰停止卡介苗复种计划对结核病总体持续下降没有影响。在结核病发病率较低的国家,卡介苗复种的效果似乎很低或不存在。

相似文献

1
Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence.卡介苗复种在结核病发病率低的情况下存在疑问。
Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1324-7. doi: 10.1164/ajrccm.157.4.9706037.
2
Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.香港出生时接种卡介苗的队列中卡介苗再接种计划的效果。
Int J Tuberc Lung Dis. 2001 Aug;5(8):717-23.
3
Evaluation of the BCG revaccination programme of schoolchildren in Finland.芬兰学童卡介苗再接种计划的评估
Bull Int Union Tuberc Lung Dis. 1991 Mar;66(1):57-9.
4
Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.卡介苗复种对巴西学龄儿童结核病发病率的影响:卡介苗复种(BCG-REVAC)整群随机试验
Lancet. 2005 Oct 8;366(9493):1290-5. doi: 10.1016/S0140-6736(05)67145-0. Epub 2005 Aug 31.
5
Revaccination with Bacillus Calmette-Guerin (BCG) vaccine does not reduce morbidity from malaria in African children.用卡介苗(BCG)对非洲儿童进行再接种并不能降低疟疾的发病率。
Trop Med Int Health. 2007 Feb;12(2):224-9. doi: 10.1111/j.1365-3156.2006.01766.x.
6
Risk of tuberculosis infection and tuberculous meningitis after discontinuation of Bacillus Calmette-Guerin in Beijing.北京停用卡介苗后结核感染及结核性脑膜炎的风险
Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1314-7. doi: 10.1164/ajrccm.162.4.9911106.
7
Tuberculosis in Bacillus Calmette-Guérin-immunized and unimmunized children in Sweden: a ten-year evaluation following the cessation of general Bacillus Calmette-Guérin immunization of the newborn in 1975.
Pediatr Infect Dis J. 1987 Mar;6(3):272-80. doi: 10.1097/00006454-198703000-00014.
8
Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial.BCG 复种对巴西学龄儿童结核病发病率影响的证据:BCG-REVAC 群组随机试验的第二次报告。
Vaccine. 2011 Jul 12;29(31):4875-7. doi: 10.1016/j.vaccine.2011.05.023. Epub 2011 May 25.
9
Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.更广泛地使用世界上使用最广泛的疫苗:重新考虑卡介苗复种。
J R Soc Interface. 2013 Jul 31;10(87):20130365. doi: 10.1098/rsif.2013.0365. Print 2013 Oct 6.
10
Design of the Brazilian BCG-REVAC trial against tuberculosis: a large, simple randomized community trial to evaluate the impact on tuberculosis of BCG revaccination at school age.巴西针对结核病的卡介苗复种试验(BCG-REVAC)设计:一项大型、简单随机的社区试验,旨在评估学龄期卡介苗复种对结核病的影响。
Control Clin Trials. 2002 Oct;23(5):540-53. doi: 10.1016/s0197-2456(02)00216-7.

引用本文的文献

1
Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix?改进卡介苗再接种策略:是要召回记录,还是干脆称其为凤凰涅槃?
Hum Vaccin Immunother. 2024 Dec 31;20(1):2300158. doi: 10.1080/21645515.2023.2300158. Epub 2024 Jan 29.
2
Comparison of the Immunogenicity and Efficacy of rBCG-EPCP009, BCG Prime-EPCP009 Booster, and EPCP009 Protein Regimens as Tuberculosis Vaccine Candidates.作为结核病候选疫苗的重组卡介苗-EPCP009、卡介苗初免-EPCP009加强免疫以及EPCP009蛋白方案的免疫原性和效力比较
Vaccines (Basel). 2023 Nov 22;11(12):1738. doi: 10.3390/vaccines11121738.
3
Protective Effect of BCG and Neutrophil-to-Lymphocyte Ratio on Latent Tuberculosis in End Stage Renal Disease.
卡介苗和中性粒细胞与淋巴细胞比值对终末期肾病患者潜伏性结核的保护作用
Infect Dis Ther. 2023 Jul;12(7):1907-1920. doi: 10.1007/s40121-023-00839-5. Epub 2023 Jul 6.
4
Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease.重新审视钦格勒布卡介苗接种试验,研究卡介苗复种对结核病发病的影响。
Indian J Med Res. 2023 Feb-Mar;157(2&3):152-159. doi: 10.4103/ijmr.ijmr_1540_22.
5
BCG revaccination boosts adaptive polyfunctional Th1/Th17 and innate effectors in IGRA+ and IGRA- Indian adults.BCG 复种可增强印度成年人中 IGRA+和 IGRA-者的适应性多功能 Th1/Th17 和先天效应细胞。
JCI Insight. 2019 Dec 19;4(24):130540. doi: 10.1172/jci.insight.130540.
6
Current status of new tuberculosis vaccine in children.儿童新型结核病疫苗的现状
Hum Vaccin Immunother. 2016 Apr 2;12(4):960-70. doi: 10.1080/21645515.2015.1120393. Epub 2016 Mar 22.
7
Tuberculin skin test distribution following a change in BCG vaccination policy.卡介苗接种政策改变后的结核菌素皮肤试验分布情况
PLoS One. 2014 Jan 23;9(1):e86419. doi: 10.1371/journal.pone.0086419. eCollection 2014.
8
Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model.基于β-防御素-2 和分枝杆菌抗原 ESAT6 或 Ag85B 的 DNA 疫苗初免-加强卡介苗接种可改善结核实验模型中的保护作用。
Vaccine. 2013 Jan 11;31(4):676-84. doi: 10.1016/j.vaccine.2012.11.042. Epub 2012 Nov 26.
9
Boosting of cellular immunity against Mycobacterium tuberculosis and modulation of skin cytokine responses in healthy human volunteers by Mycobacterium bovis BCG substrain Moreau Rio de Janeiro oral vaccine.牛分枝杆菌卡介苗莫罗里约热内卢口服疫苗对健康人类志愿者抗结核分枝杆菌细胞免疫的增强及皮肤细胞因子反应的调节
Infect Immun. 2006 Apr;74(4):2449-52. doi: 10.1128/IAI.74.4.2449-2452.2006.
10
Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein.通过用结核分枝杆菌主要分泌蛋白进行加强免疫来提高牛分枝杆菌卡介苗接种对结核病的保护效力。
Infect Immun. 2005 Aug;73(8):4676-83. doi: 10.1128/IAI.73.8.4676-4683.2005.